Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Michael Saccente

Concepts (110)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Histoplasmosis
2
2021
47
0.910
Why?
Acquired Immunodeficiency Syndrome
3
2021
54
0.780
Why?
Lymphogranuloma Venereum
1
2022
1
0.770
Why?
Proctocolitis
1
2022
1
0.770
Why?
Pneumonia, Pneumocystis
1
2021
6
0.750
Why?
Pneumocystis carinii
1
2021
4
0.750
Why?
beta-Glucans
1
2021
23
0.740
Why?
Sweet Syndrome
1
2021
10
0.710
Why?
Mycobacterium Infections, Nontuberculous
1
2021
19
0.700
Why?
Inflammatory Bowel Diseases
1
2022
85
0.680
Why?
Antifungal Agents
4
2008
347
0.650
Why?
Citrus paradisi
2
2008
10
0.510
Why?
Food-Drug Interactions
2
2008
14
0.510
Why?
Itraconazole
2
2008
38
0.510
Why?
HIV Infections
3
2006
389
0.450
Why?
Blastomyces
1
2010
17
0.330
Why?
Blastomycosis
1
2010
31
0.330
Why?
Beverages
2
2008
57
0.290
Why?
Candida
1
2008
63
0.280
Why?
Arthritis, Infectious
1
2008
43
0.280
Why?
Candidiasis
1
2008
113
0.270
Why?
Anti-Retroviral Agents
1
2006
19
0.260
Why?
Mycobacterium fortuitum
1
2006
6
0.250
Why?
Joint Diseases
1
2006
39
0.240
Why?
Tuberculosis
2
2009
152
0.240
Why?
Patient Compliance
1
2006
230
0.240
Why?
beta-Cyclodextrins
1
2004
17
0.220
Why?
Prosthesis-Related Infections
1
2006
107
0.220
Why?
Humans
18
2022
52483
0.210
Why?
Amphotericin B
1
2003
103
0.200
Why?
Male
11
2022
26761
0.200
Why?
Glucans
1
2021
10
0.190
Why?
Tuberculin Test
1
2001
9
0.190
Why?
Homosexuality, Male
1
2022
52
0.180
Why?
Adult
9
2021
14161
0.180
Why?
Infectious Disease Transmission, Vertical
1
2000
16
0.170
Why?
Autoantibodies
1
2021
121
0.170
Why?
Interferon-gamma
1
2021
180
0.170
Why?
Cat-Scratch Disease
1
1999
7
0.170
Why?
Liver Abscess
1
1999
5
0.170
Why?
Retinitis
1
1999
5
0.170
Why?
Meningitis
1
1999
24
0.160
Why?
Optic Neuritis
1
1999
21
0.160
Why?
Klebsiella Infections
1
1999
13
0.160
Why?
Klebsiella pneumoniae
1
1999
20
0.160
Why?
Facial Paralysis
1
1999
25
0.160
Why?
Vancomycin Resistance
1
2019
6
0.160
Why?
Endophthalmitis
1
1999
24
0.160
Why?
Chronic Disease
1
2022
586
0.160
Why?
Diabetes Complications
1
1999
122
0.150
Why?
Vancomycin
1
2019
85
0.150
Why?
Pharmaceutical Solutions
2
2008
9
0.130
Why?
Macrophages
1
2019
379
0.130
Why?
Staphylococcal Infections
1
2019
285
0.130
Why?
Area Under Curve
2
2008
180
0.120
Why?
Staphylococcus aureus
1
2019
338
0.120
Why?
Cross-Over Studies
2
2008
238
0.120
Why?
Anti-Bacterial Agents
1
2019
807
0.100
Why?
Female
8
2010
28171
0.100
Why?
Ixodes
1
2010
6
0.080
Why?
Arthroplasty, Replacement, Knee
2
2006
289
0.080
Why?
Lyme Disease
1
2010
31
0.080
Why?
Borrelia burgdorferi
1
2010
31
0.080
Why?
Retrospective Studies
1
2021
6607
0.080
Why?
Pancreatic Diseases
1
2009
17
0.080
Why?
AIDS-Related Opportunistic Infections
1
2009
38
0.080
Why?
Drug Resistance, Fungal
1
2008
34
0.070
Why?
Cytochrome P-450 CYP3A
1
2008
78
0.070
Why?
Administration, Oral
1
2008
451
0.070
Why?
Sex Factors
1
2008
727
0.060
Why?
Cyclodextrins
1
2004
18
0.060
Why?
Critical Illness
1
2006
317
0.050
Why?
Biological Availability
1
2004
108
0.050
Why?
Middle Aged
4
2009
13028
0.050
Why?
Burkholderia
1
2002
9
0.050
Why?
Ultrasonics
1
2002
29
0.050
Why?
Staphylococcus
1
2002
34
0.050
Why?
Fatal Outcome
1
2003
197
0.050
Why?
Knee Prosthesis
1
2002
52
0.050
Why?
Hip Prosthesis
1
2002
71
0.050
Why?
Biofilms
1
2002
191
0.040
Why?
Scotoma
1
1999
7
0.040
Why?
Fundus Oculi
1
1999
24
0.040
Why?
Arkansas
2
2010
2028
0.040
Why?
Visual Field Tests
1
1999
15
0.040
Why?
Lysostaphin
1
2019
2
0.040
Why?
Multilocus Sequence Typing
1
2019
7
0.040
Why?
Daptomycin
1
2019
29
0.040
Why?
Aged
3
2019
10121
0.040
Why?
Cell Wall
1
2019
59
0.040
Why?
Prenatal Care
1
2000
110
0.040
Why?
Arthroplasty, Replacement, Hip
1
2002
266
0.040
Why?
Bacteremia
1
2019
92
0.040
Why?
Microbial Sensitivity Tests
1
2019
284
0.040
Why?
Mass Screening
1
2000
357
0.030
Why?
Incidence
1
2000
1062
0.030
Why?
Mutation
1
2019
1347
0.030
Why?
Pregnancy
1
2000
2680
0.030
Why?
Infant, Newborn
1
2000
2867
0.020
Why?
Risk Factors
1
2000
3889
0.020
Why?
Antiretroviral Therapy, Highly Active
1
2009
32
0.020
Why?
HIV-1
1
2009
59
0.020
Why?
Adolescent
1
2000
6739
0.020
Why?
Antitubercular Agents
1
2009
107
0.020
Why?
Mycobacterium tuberculosis
1
2009
291
0.020
Why?
Filtration
1
2002
22
0.010
Why?
Colony Count, Microbial
1
2002
63
0.010
Why?
Prospective Studies
1
2002
2481
0.010
Why?
Aged, 80 and over
1
2002
3392
0.010
Why?
Animals
1
2010
13505
0.010
Why?
Saccente's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description